Close

Publications

The effect of RTS,S/AS01E and SMC alone or combined on the acquisition of blood stage antimalarial antibody responses.
PATTERSON, C; SOREMEKUN, S; Dicko, A; Ouedraogo, J-B; Zongo, I; Sagara, I; Snell, P; Lee, C; Ockenhouse, C; Ofori-Anyinam, O; Tinto, H; CHANDRAMOHAN, D; GREENWOOD, B; DRAKELEY, C;
2024
(2024).
Does the improved impact of dual active ingredient nets on malaria control last 3 years? Results from randomised controlled trials.
NGUFOR, C;
2024
(2024).
School-based malaria chemoprevention as a cost-effective approach to improve cognitive and educational outcomes: a meta-analysis.
Angrist, N; Jukes, MC H; Clarke, S; CHICO, RM; OPONDO, C; Bundy, D; Cohee, LM;
2024
(2024).
Identification of the PfK13 mutations R561H and P441L in Democratic Republic of Congo (DRC): and a snapshot of prevalence and diversity at antimalarial drug resistance loci in P. falciparum across the DRC.
Kahunu, GM; Wellmann-Thomsen, S; Wellmann-Thomsen, L; Hypolite, MM; Patrick, MM; Filtenborg Hocke, E; CHICO, RM; Beshir, KB; SUTHERLAND, CJ; Chopo-Pizarro, A; Papy, MN; Baraka, V; Minja, DT R; MOUSA, A; Mbongi, MD; Mumba-Ngoyi, D; Mukomena Sompwe, D; Muyembe Tanfum, JJ; ROPER, C; Hansson, H; Alifrangis, M;
2024
(2024).MH4 Category: Drug Resistance 5 Scientific Session N° 56
Concurrent declines in malaria incidence among children under and over five years of age in Koutiala, Mali: time series analysis of seasonal malaria chemoprevention from 2012-2022.
Maiga, H; OPONDO, C; Cohee, LM; Coulibaly, O; Alaofari, M; CHICO, RM;
2024
(2024).MH4 Category: Drug Resistance 5 Scientific Session N° 56
A systematic review of non-malarial effects of malaria chemoprevention interventions.
Gross, M; McGirr, A; CHICO, RM; Stresman, G;
2024
(2024).MH1 Category: Chemoprevention 3 Scientific Session N° 40
Modelling the potential impact of perennial malaria chemoprevention with sulfadoxine pyrimethamine in Cameroon.
Atkinson, I; MOUSA, A; Ali, I; Winskill, P; Nji, A; Voundi, J; PITT, C; McGirr, A; MARTÍNEZ-VEGA, R; CHICO, RM; Beshir, KB; Chopo-Pizarro, A; Filtenborg-Hocke, E; Hansson, H; Alifrangis, M; Gosling, R; Mbacham, WF; ROPER, C; Okell, L;
2024
(2024).MH4 Category, Chemoprevention 1 Scientific Session N° 6
Characterisation of Plasmodium falciparum antimalarial drug resistance marker profiles in polyclonal/mixed infections by Illumina targeted sequencing.
Chico, RM; Hansson, H; Pedersen-Ebbe Midtboell, M; Filtenborg Hocke, E; CHICO, RM; Beshir, KB; Chopo-Pizarro, A; MOUSA, A; SUTHERLAND, CJ; ROPER, C; Alifrangis, M;
2024
(2024).MH4 Category: Drug Resistance Scientific Session N° 56
Social determinants of malaria chemoprevention among children in sub-Saharan Africa: a systematic review.
Mosoff, JM; CHICO, RM; LAL, S;
2024
(2024).
Bickersmith, SA; Saavedra, MP; Prussing, C; Lange, RE; Morales, JA; Alava, F; Vinetz, JM; Gamboa, D; Moreno, M; Conn, JE;
2024
Malaria Journal, (2024).23 1 10.1186/s12936-024-04940-z.